Thymus regeneration in countering immunosenescence: Mechanisms, strategies and future perspectives.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing mechanisms and interventional strategies without systematic review methodology.
PubMed 42595186 · doi:10.1016/j.arr.2026.103300
What was done
This review summarizes the biological mechanisms underlying age-related thymic involution and evaluates therapeutic strategies for thymic regeneration. Approaches reviewed include modulation of the growth hormone/IGF-1 axis, cytokine-based interventions, mTOR inhibitors, sex steroid ablation, stem cell and cell-based therapies, gene therapy, and tissue engineering.
What was found
The abstract provides no quantitative empirical data or statistical effect sizes. It describes the pathological trajectory of thymic involution, characterized by diminished naive T-cell production, decreased T-cell receptor repertoire diversity, and increased systemic inflammaging, and lists intervention strategies under investigation.
Why it matters
Age-related thymic atrophy is a primary driver of adaptive immune decline. Reversing this process through targeted regenerative interventions represents a foundational strategy for restoring immune homeostasis and countering immunosenescence.
Limits
This is a narrative review containing no new primary human or animal data. The abstract does not detail specific study inclusion criteria, effect sizes, risk-of-bias assessments, or safety profiles for the evaluated therapeutic modalities.
Cited by
- supports The human thymus gland gradually shrinks in size as a person ages.